COMPREHENSIVE CELL SOLUTIONS
LIVE

Serial Number

86881963

Owner

New York Blood Center, Inc.

Attorney

CYNTHIA JOHNSON WALDEN

First Use Date

Feb 11, 2016

Filing Date

Jan 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

COMPREHENSIVE CELL SOLUTIONS Trademark

Serial Number: 86881963 • Registration: 5234078

COMPREHENSIVE CELL SOLUTIONS is a trademark filed by New York Blood Center, Inc. on January 21, 2016. The trademark is classified under Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

New York Blood Center, Inc.

310 East 67th Street
New York, NY 10021

Entity Type: 99

Trademark Details

Filing Date

January 21, 2016

Registration Date

June 27, 2017

First Use Anywhere

February 11, 2016

First Use in Commerce

February 11, 2016

Goods & Services

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely storage of blood and stem cells

[ Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes ]

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory and research and pharmaceutical research services and pharmaceutical clinical trials for others

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 27, 2026 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 20, 2024 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Feb 20, 2024 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 20, 2024 APRE
TEAS SECTION 8 RECEIVED
Dec 22, 2023 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 27, 2022 REM1
REGISTERED-SUPPLEMENTAL REGISTER
Jun 27, 2017 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 23, 2017 PREV
ASSIGNED TO LIE
May 22, 2017 ALIE
ASSIGNED TO LIE
May 10, 2017 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 17, 2017 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 12, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 18, 2016 GNFN
FINAL REFUSAL E-MAILED
Nov 18, 2016 GNFR
FINAL REFUSAL WRITTEN
Nov 18, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2016 NWOS
NEW APPLICATION ENTERED
Jan 25, 2016 NWAP